Entry Inhibitors in Development

CCR5/CCR2 Antagonist Cenicriviroc: 24-Week Data vs. Efavirenz in ART-Naive (March 8, 2013)
From National AIDS Treatment Advocacy Project
New Drug Hits HIV and Inflammatory Processes (March 7, 2013)
From MedPage Today
New Antiretroviral Agents: Cenicriviroc (Video) (March 7, 2013)
From HIVandHepatitis.com
New HIV Drug Cenicriviroc Shows Non-Inferiority to Efavirenz and Activity Against Inflammation, Study Finds (March 6, 2013)
In The 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013), from TheBodyPRO.com
Dual CCR5/CCR2 Inhibitor Cenicriviroc Has Both Anti-HIV and Anti-Inflammatory Effects (March 4, 2013)
From HIVandHepatitis.com
Long-Acting Drug in Development (November/December 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
On TheBodyPRO.com
An Overview of PRO-140 (October 22, 2012)
From AIDSinfo
An Overview of Ibalizumab (October 22, 2012)
From AIDSinfo
An Overview of Cenicriviroc (October 22, 2012)
From AIDSinfo
An Overview of BMS-663068 (October 22, 2012)
From AIDSinfo

VIEW ALL ARTICLES

More Most Viewed Articles

HIV Tools You Can Use

Track Your CD4 Count, Viral Load and More: Use TheBody.com's Health Tracker

TheBody.com's App for iPhones
TheBody.com's Medication and Health Reminders
TheBody.com's Facebook, Widgets, RSS Feeds and Twitter
Are You at Risk for HIV? Take Our Quiz!
U.S. ASO Finder U.S. ASO Listings
International ASOs

The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.